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Escherichia coli serotype O157:H7 was first recognized in 1982 as a human pathogen 
associated with outbreaks of bloody diarrhea in the United States and is now considered 
a major cause of foodborne infections because of its high hospitalization rate. Cattle is 
the major reservoir of E. coli O157:H7. Cattle harbor E. coli O157:H7 in the hindgut 
and shed the organisms in the feces, which serves as a source of contamination of food 
and water. It is hypothesized that dietary ingredients that reach the hindgut are likely to 
affect colonization and fecal shedding of STEC. Increased flow of dietary ingredients 
(starch, fiber, protein, and lipid) are likely to alter ecology of the hindgut, resulting in 
altered pH and fermentation products, which could have a positive or negative impact 
on E. coli O157:H7. The objectives of this study are to investigate E. coli O157:H7 
populations in fecal shedding of cattle. The cattle in this study were fed with diets with 
  
different levels of ruminally-degradable and –undegradable protein. A total of 286 E. 
coli O157:H7 isolates were recovered from feces of 576 crossbred calves at the Clayton 
Livestock Research Center in Clayton, New Mexico. The organisms were sequenced 
using Illumina Miseq system. De novo assembly of raw reads was performed using 
SPAdes and SNPs analysis of the isolates was conducted using kSNP3. Virulence factor 
Database (VFDB), created by the MOH key laboratory of Systems Biology of 
Pathogens, Institute of Pathogen Biology, was used as a reference for BLAST. The 
results indicated that increased flow of undegradable protein may increase the shedding 
of E. coli O157. However, the effect of ractopamine was still unknown. Three clades 
were identified among the E. coli O157:H7 isolates, including clades 6, 7, and 8, most 
of which belong to clade 8 (205 of 286). 49588 SNPs were found according to kSNP3. 
19043 SNPs were identified as core SNPs. The phylogenetic analysis showed that the 
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CHAPTER 1 Introduction 
1. Overview of Shiga toxin-producing Escherichia coli (STEC) 
Escherichia coli (also known as E. coli) is a gram-negative, facultatively 
anaerobic, rod-shaped, coliform bacterium of the genus Escherichia that is 
commonly found in the environment, foods, and intestines of people and animals. 
Most E. coli are harmless, in fact, are important component of human intestinal 
tract. However, some E. coli can cause severe illness. They can be transmitted 
through contaminated food or water, contact with animals, or person-to-person. E. 
coli that cause diarrheal disease are divided into six pathotypes based on their 
virulence factors: enteropathogenic E. coli (EPEC); enterotoxigenic E. coli 
(ETEC); enteroaggregative E. coli (EAEC); enteroinvasive E. coli (EIEC); 
enterohemorrhagic E. coli (EHEC) (2). The term EHEC is often used 
interchangeably with “STEC” and is intended to denote the subset of STEC 
capable of causing bloody diarrhea or HUS (3). However, because different 
definitions of EHEC have been used in the scientific literature, to minimize 
confusion, “STEC” has been used by the Center for Disease Control and 
Prevention (CDC) (3). 
The E. coli that can make Shiga toxin are called Shiga toxin-producing 
Escherichia coli (STEC). STEC are estimated to cause more than 265,000 illness 
each year in the United States, with more than 3600 hospitalization and 30 deaths 
(4). STEC cause a potentially fatal zoonotic foodborne illness whose clinical 
spectrum includes nonspecific diarrhea, hemorrhagic colitis, and the hemolytic 
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uremic syndrome (HUS) (2, 5-7). Up to 40% of patients with HUS develop long-term 
renal dysfunction, and about 3-5% of death patients during the acute phase of the 
disease (8-11). 
1.1 Pathogenicity and virulence factors of STEC 
The ability to produce one or more of the Shiga toxin (stx) family cytotoxins 
constitutes the main virulence attribute of STEC (12). The presence of Shiga toxin 1 
or 2 gene (stx1 or stx2) is responsible for the pathogenesis of STEC. However, there 
several other factors are also involved. The attaching and effacing (A/E) lesion 
formation is caused by the type III secretion system (T3SS) encoded by the locus of 
enterocyte effacement (LEE), which injects small effector proteins into the host cell 
(13, 14), and thus are grouped as LEE-positive STEC. STEC pathogenesis is a 
multistep process, and besides the production of stx toxins and the A/E lesion, other 
factors including different types of toxins and adhesions have been described and 
found to be involved in virulence (15). 
1.1.1 Shiga toxin 
Shiga toxin is the main characteristic that defines STEC and is the key virulence 
factor in STEC causing HUS (16). Several in-depth reviews have been published 
regarding the mechanism of action in renal cells (positive for cell surface 
globtriaosylceramide [Gb3+]) (17),the intestinal epithelium (Gb3-) (18), and the 
vascular endothelium (Gb3+) (19) and its contribution to the pathophysiology of HUS 
(20).  
Shiga toxins can be divided into two types, Stx1 and Stx2, with Stx1 having 3 
subtypes (a, c and d), and Stx2 having 7 subtypes(a to g) (21). STEC can carry a 
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single Shiga toxins variant, either stx1 or stx2, both stx1 and stx2, or a combination of 
stx2 subtypes (16). Both stx1- and stx2-containing STEC can lead to HUS; however, 
stx2 is more often associated with severe disease (22).  
Both Stx1 and Stx2 are encoded on prophages that are integrated into the 
chromosome. Shiga toxin-carrying phages can become lytic during bacterial stress, 
and it is believed that Stx1/Stx2 is released from lysed bacterial cells during the lytic 
cycle of the phage (23). Lee et al. (24) has described the mechanism of Stx delivery 
and trafficking through endothelial cells. In summary, Stx binds to Gb3 on the surface 
of endothelial cells (25, 26) and is internalized and trafficked through the retrograde 
pathway from the Golgi apparatus and endoplasmic reticulum (ER) and eventually to 
the host cell cytoplasm. However, the mechanism of Stx transport from the intestinal 
lumen across the epithelium is unknown. Schuller et al. (18) hypothesized that STEC-
induced inflammation may provide the toxin an opportunity to breach the epithelial 
barrier, and there are other possible mechanisms. STEC is able to cross the intestinal 
epithelium through microfold cells and survive in macrophages, and this may be a 
way the stx to be released into the blood stream, where it can target other organs (27). 
1.1.2 Other virulence factors 
The ability to adhere to intestinal epithelial cells is another important factor in 
STEC pathogenesis. STEC is believed to colonize the mucosa of the large bowel, with a 
characteristic attaching and effacing (A/E) cytopathology that is mediated by components 
of a an approximate 43.4-kb pathogenicity island (PAI) referred as the locus of enterocyte 
effacement (LEE) (2). The central region of LEE comprises the (28). Downstream of eae 
are the esp genes, which encode the secreted proteins EspA, EspB, EspD, and EspF, 
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while upstream are many genes (esc and sep) that are thought to encode the type III 
secretion machinery that facilitates the transport of effector molecules to their active sites 
(28). Although LEE has been described in the major EHEC/STEC serotypes responsible 
for a high proportion of HC and HUS cases in several countries, its presence is not a 
required condition for the occurrence of more serious infections as initially thought, 
because some LEE-negative strains are also capable of causing outbreaks and sporadic 
cases of HUS (29, 30). 
Another important virulence factor of STEC is enterohemorrhagic E. coli (EHEC) 
hemolysin. In STEC, ehx was found on pO157 and pO113 plasmids. The EHEC 
hemolysin (EHEC-hlyA or ehx) is a pore-forming toxin that lyses sheep erythrocytes (31, 
32). Several studies have shown some insight on the contribution of Ehx to disease 
though the role of it in virulence has been unclear. These toxins are associated as cargo 
with outer membrane vesicles (OMVs), prolonging its activity (33). Ehx was found to be 
cytotoxic to endothelial cells and may contribute to the development of HUS (34). In 
addition, Ehx was shown to be inactivated by another STEC virulence factor, EspP (35). 
1.2  Different serotypes of STEC and Escherichia coli O157:H7 (E. coli O157:H7) 
Despite over 400 STEC serotypes identified, only a subset of them have been 
correlated to illness in humans (36). The STEC can be divided into two groups: E. 
coli O157:H7 and non-O157.  
It was first recognized in 1982 as a human pathogen associated with outbreaks of 
bloody diarrhea in the United States and is now considered a major cause of foodborne 
infections. The 1993 Jack in the Box outbreak of O157:H7 which resulted in 700 people 
infected, 171 hospitalized, and 4 dead prompted major changes in the US food safety 
system. In the ten years that followed, there were approximately thirty outbreaks 
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recorded in the United States (37). This number is likely misleading, however, 
because E. coli O157:H7 infections did not become a reportable disease in any 
state until 1987, when Washington became the first state to mandate its reporting 
to public health authorities (38, 39). Consequently, an outbreak would not be 
detected if it was not large enough to prompt investigation (38, 40). The Centers 
for Disease Control and Prevention (CDC) has estimated that E. coli O157:H7 
infections cause 73,000 illness, 2200 hospitalizations, and 60 deaths annually in 
the United States (41). Although the outbreak surveillance data from CDC 
reported that E. coli O157:H7 infections are decreasing after the peak in 1999, 
large outbreaks and sporadic cases continue to occur in United States according to 
CDC reported investigations(41). E. coli O157:H7 infections are less common. 
However, the high hospitalization rate (46%, approximately 2138 cases) (4) and 
multistate infections make this E. coli serotype an important foodborne pathogen 
in the United States. Furthermore, table 1.1 shows multistate foodborne outbreak 
investigations involving E. coli O157:H7 from 2006 to 2017 according to CDC 
reports of selected E. coli O157:H7 outbreaks investigations. The annual cost of 
illness due to E. coli O157:H7 infections was 405 million dollars, including lost 
productivity, medical care, and premature deaths (42).  
The most common serogroups of non-O157 STEC reported to cause foodborne 
illness in the United States are O26, O111, O103, O121, O45, and O145, which refers 
to the “Big 6” described in a study of non-O157 STEC human illness in the United 
States between 1983 and 2002 (43). In parts of Latin America, non-O157 STEC are 
more commonly implicated in HUS than is serotype O157:H7, and account for up to 
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40% of cases of HUS in Europe and for up to 25% of cases in the United States (28). 
In a study of diarrheal outbreaks conducted in four Brazilian states, some uncommon 
serogroups including O1, O24and O77 among others were detected, but they were all 
associated with acute diarrhea. It is interesting to note that the majority of patients 
from whom STEC was isolated were female (57%), and that patients’ ages ranged 
from 8 months to 80 years, with most being less than five years old(54%) (44). 
Likewise, these serotypes of STEC are common in many parts of the world, but the 
overall prevalence differs geographically (45). 
Table 1.1 selected outbreaks of E. coli O157:H7 from 2006 to 2017 
Outbreak Year Case Hospitalizations Deaths States 
I.M. Healthy SoyNut Butter 2017 29 12 0 12 
Beef Products 2016 11 7 0 5 
Rotisserie Chicken Salad 2015 19 5 0 7 
Ground Beef 2014 12 7 0 4 
Ready-to-Eat Salads 2013 33 7 0 4 
Spinach and Spring Mix 2012 33 13 0 5 
Romaine Lettuce 2011 49 33 0 9 
Lebanon Bologna 2011 13 3 0 5 
Hazelnuts 2011 8 4 0 3 
Cheese 2010 38 15 0 5 
Beef 2010 21 9 0 16 
Beef 2009 26 19 0 8 
Beef 2009 23 12 0 9 
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Prepackaged Cookie Dough 2009 72 34 0 30 
Beef 2008 49 27 0 7 
Pizza 2007 21 8 0 10 
Ground Beef Patties 2007 40 21 0 8 
Mexican Restaurant Chain 2006 71 53 0 5 
Fresh Spinach 2006 199 102 3 26 
 
1.3  Reservoirs of STEC 
Microbes live throughout the gastrointestinal tract of mammals, including 
ubiquitous and adaptable E. coli. Ruminants such as cattle, both meat and dairy, 
are widely known to be major reservoirs for pathogenic STEC, and exposure to 
their fecal matter represents an important source of human illness (46). A survey 
of ground beef in the United States showed that approximately 24% of samples 
tested were positive for stx genes by PCR, with only a small proportion of isolates 
being potentially pathogenic to humans (47). STEC O157:H7 has been isolated 
from other animals and insects, which include but are not limited to swine, sheep, 
deer, wild boars, rabbits, birds, dogs, rodents, and insects (48). Certain STEC 
serotypes, such as O157:NM, and O104:H4, have rarely been or have not been 
reported as being isolated from animals (49, 50). During the 2011 European 
outbreak of 4,321 cases, fenugreek sprouts were identified as the most likely 
source of infection (51). The seeds were imported as a lot in late 2009 from Egypt, 
and it is still unknown if the point of contamination occurred at the site where 
seeds were produced, during transportation, or at the importer (51). Furthermore, 
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it was determined that cattle were not a reservoir for the 2011 European outbreak of 
STEC O104:H4 (52). Finally, human-to-human transmission did occur during the 
STEC O104:H4 infection in Poland, France, Germany, and the Netherlands during the 
outbreak (53-57).  
As the most important foodborne pathogen affecting human health worldwide, E. 
coli O157:H7 is most commonly found in cows, although chickens, deer, sheep, and 
pigs have also been known to carry it. A 2003 study on the prevalence of E. coli 
O157:H7 in livestock at 29 county and three large agricultural fairs in the United States 
found that E. coli O157:H7 was isolated from 13.8% of beef cattle, 5.9% of sheep, and 
2.8% of goats (58). Over 7% of pest fly pools also tested positive for E. coli O157:H7 
(58). Among these animals, cattle is the major reservoir of STEC. Cattle harbor STEC 
in the hindgut and shed the organisms in the feces, which serves as a source of 
contamination of food and water. 
1.4 Dietary effects on E. coli O157:H7 shedding in cattle 
Ground beef is the most frequently implicated source of E. coli O157:H7 
outbreaks, and bovine-derived products are linked to approximately 75% of E. coli 
O157:H7 outbreaks (59, 60). Cattle are a major reservoir of E. coli O157:H7 and 
repeated hemorrhagic colitis outbreaks linked to consumption of ground beef, animal 
contact, manure amendation, or cattle manure contaminated runoff has firmly 
established the connection between cattle and E. coli O157:H7 epidemiologically, and 
in public perception (61-63).  
Fecal shedding of STEC is influenced by several factors and diet is one of the 
major factors. It is hypothesized that dietary ingredients that reach the hindgut are 
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likely to affect colonization and fecal shedding of STEC. Increased flow of dietary 
ingredients (starch, fiber, protein, and lipid) are likely to alter ecology of the hindgut, 
resulting in altered pH and fermentation products, which could have a positive or 
negative impact on STEC. Increased flow of protein into the hindgut resulting in 
increased ammonia concentration could increase the gut pH and possibly favor 
colonization of STEC. Therefore, it would be of interest to determine fecal shedding 
of STEC in cattle fed diets supplemented with different levels of ruminally-
degradable or –undegradable protein. 
Ractopamine hydrochloride is a beta-adrenergic agonist that is used as a feed 
additive to improve growth performance and carcass quality (64).Beta-adrenergic 
agonists are physiologically and pharmacologically similar to natural catecholamines, 
such as epinephrine and norepinephrine (65).Several studies have reported on the 
effects of natural catecholamines on growth of bacteria. Norepinephrine and dopamine 
induced growth of E. coli O157:H7 and Salmonella enterica has been reported (66). 
Catecholamines have also been shown to induce expressions of virulence genes, such 
as Shiga toxins (67).Increased bacterial growth has been attributed to the increased iron 
availability to the bacteria due to interaction of catecholamines with host-iron binding 
protein (68).Also, catecholamine might induce stimulation of bacterial growth and 
virulence gene expression of E. coli O157:H7 via quorum sensing mechanisms (69-71). 
In view of the effects of natural catecholamines on bacteria, several studies have been 
conducted to assess the effects of their synthetic counterparts, beta-adrenergic agonists 
on fecal shedding of E. coli O157:H7. Edrington et al. (2006b) showed increased cecal 
population and fecal shedding of E. coli O157:H7, following oral inoculation of the 
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pathogen in sheep administered with ractopamine hydrochloride.  On the contrary, 
there was decreased fecal shedding of Salmonella in experimentally inoculated pigs 
administered with ractopamine hydrochloride (72). Edrington et al., 2006 (73) have 
also reported decreased fecal shedding of E. coli O157:H7, but increased shedding of 
Salmonella in cattle administered with ractopamine hydrochloride. Also, there are 
reports of no effects of ractopamine on fecal shedding of E. coli O157:H7 in cattle (74, 
75).Walker and Drouillard (76)reported that ractopamine feeding decreases proteolysis 
due to its direct effect on ruminal bacteria that break down amino acids, which resulted 
in decreased ammonia concentration. Although natural catecholamines are known to 
increase bacterial growth and gene expressions, there are contradictory reports 
regarding the effects of ractopamine on fecal shedding of E. coli O157:H7. There has 
been no study reported on the effects of ractopamine on fecal shedding of non-O157 
STEC. Therefore, further research is warranted to investigate the effect of ractopamine 
on fecal shedding of STEC. 
2. Next-generation sequencing technology 
Next-generation sequencing (NGS), also called massive parallel sequencing, was 
developed in the last decade and allows simultaneous sequencing of millions of DNA 
fragments without previous sequence knowledge (77). The Sanger DNA sequencing 
method, also named chain terminator sequencing, is a technique for DNA sequencing 
based on the selective incorporation of chain-terminating dideoxynucleotides 
(ddNTPs) by DNA polymerase during in vitro DNA replication, was developed by 
Frederick Sanger and colleagues in 1997. This method, which was later automated 
and underwent slight modifications, was the sequencing gold standard until late 
11 
 
2000’s (78).  
Due to the high costs and intensive work required, traditional sequencing was 
only performed on specific DNA regions and for specific samples (77). Compared to 
the traditional Sanger capillary electrophoresis sequencing method (79, 80), which is 
considered a first-generation sequencing technology, NGS technologies provide 
higher throughput data with lower cost and enable population-scale genome research. 
NGS technologies have three major improvements compared to first-generation 
sequencing: first, NGS methods do not require a bacterial cloning procedure and pre-
pare libraries for sequencing in a cell free system; second, NGS technologies process 
millions of sequencing reactions in parallel and at the same time; third, detection of 
bases is performed cyclically and in parallel (81).  
Current NGS technology is sorted in two major types, i.e., short- and long-read 
sequencing (77). Short-read sequencing is mainly performed by Illumina® protocols 
and machines and is described as cheap “sequencing by synthesis” (SBS) of reads 
shorter than 300bp (82). The ion semiconductor method (Ion Torrent®) is another 
cheap short-read sequencer (83). The long-read sequencing is performed mainly by 
PacBio® or Roche®, is a costly “single molecule real-time” (SMRT) technology of 
reads longer than 2.5 Kb (84, 85). The Oxford Nanopore Technologies® MinION, 
using single stranded pore technology, actually allows to sequence very long 
molecules (>10 Kb) (86) and at a relative low cost but with a relatively higher error 
rate compared with other sequencers. The advances of NGS technology has led to 
decreasing cost and growing speed of Whole Genome Sequencing (WGS) (87). The 
WGS data can be used to identify the phylogeny, virulence factors, SNPs of 
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microorganisms efficiently to help us better understand the organism and detect the 
outbreak associated with foodborne pathogen.  
3. Clade identification of E. coli O157:H7 
Several recent outbreaks involving E. coli O157:H7 contamination of fresh 
produce were associated with more severe disease, as defined by higher hemolytic 
uremic syndrome and hospitalization frequencies, suggesting that increased virulence 
has evolved. To test this hypothesis, Manning et al. has developed a system that 
detects SNPs in 96 loci and applied it to more than 500 E. coli O157:H7 clinical 
strains. As a result, the analyses in their study identified 39 SNP genotypes that differ 
at 20% of SNP loci and separated E. coli O157:H7 into nine distinct clades. The study 
showed the SNP differences between strains associated with outbreaks and which 
lineage might have acquired critical factors that contribute to more severe disease. In 
addition, the ability to detect genotype O157 strains belonging to such lineages, 
identify more virulent O157 subtypes of this useful, rapid, and inexpensive molecular 
test proposed in this study will have significant impact on both disease diagnosis and 
treatment guidelines, and also, would be useful for clinical laboratories to identify 
patients with an increased likelihood of developing HUS. 
Study Objectives: 
The objectives of our study were to investigate a possible link of dietary protein 
levels to E. coli O157:H7 populations in fecal shedding of cattle by analyzing the 
WGS data of 311 isolates. 
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CHAPTER 2 Materials and methods 
1. Animals and Facilities.  
 A total of 576 crossbred calves at the Clayton Livestock Research Center in Clayton, New 
Mexico were used for this study. Cattle were housed in soil-surfaced pens (40 ft. x 115 ft.) with 
36 ft. of bunk space. Water was supplied to each pen with a metered water tank (Cattlemaster 
480, Ritchie Inc.). Cattle were fed a diet to gain approximately 2 pounds daily until they reach 
approximately 850 pounds, at which time the dietary treatments were given to those cattle for 
this proposed study. 
2. Experimental Design and Treatments.  
The cattle were weighed individually, given a commercial growth implant, and ranked in a 
spreadsheet by body weight after they reached approximately 850 pounds. Then calves were 
separated into 4 blocks based on body weight. Within each block, calves were assigned 
consecutively to pens so that the average weight and standard deviation of a pen can be similar 
among pens. As a result the study became to a randomized complete block design consisting 
of 48 soil-surfaced pens (40 ft. x 115 ft. with 36 ft. bunk line) and 4 blocks (figure 2.1). Pen 
were served as the experimental unit. Within each block, pens of cattle were randomly assigned 








Figure 2.1 Pen assignments and tag colors 
 
Dietary treatments were initiated once cattle were weighed using a pen scale and adapted 
to a finishing diet. These dietary treatments were consisted of steam-flaked corn-based 
finishing diets and shown in table 2.1. The diets were first administered 35 days before harvest. 
Cattle in blocks 3 & 4 were first administered the diet on August 23rd, 2015, and cattle in block 
1 & 2 on August 30th, 2015. For pens receiving ractopamine, it was administered in the diet on 
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four days (table 2.2). 
Table 2.1 Components of each diet in this study 
 Crude protein Degradable protein Undegradable protein ractopamine 
Control Diet 1 14.5% 9.2% 5.3% 0 
Control Diet 2 14.5% 9.2% 5.3% 400 mg 
High Degradable diet 1 19.5% 13.2% 6.5% 0 
High Degradable diet 2 19.5% 13.2% 6.5% 400 mg 
High Undegradable diet 1 19.5% 9.2% 10.2% 0 
High Undegradable diet 2 19.5% 9.2% 10.2% 400 mg 
 
Table 2.2 Treatments given date for each block 
 Dietary treatment given Rh given 
Block 1 8/30/2015 9/9/2015 
Block 2 8/30/2015 9/7/2015 
Block 3 8/23/2015 9/4/2015 
Block 4 8/23/2015 9/2/2015 
3. Fecal sample collection and processing.  
Freshly-defecated fecal pats on the pen floor were sampled with a plastic spoon 
(two to three spoonful). Care will be taken while sampling to avoid ground 
contamination. The spoon with feces were placed into a Whirl-pack bag (Nasco, Ft. 
Atkinson, WI), and placed in a cooler with ice packs. Six fecal samples were collected 
from each pen and labeled with pen numbers and sample numbers, thus blinding 
laboratory personal to treatment assignments. Samples were sent to the Kansas State 
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University College of Veterinary Medicine Pre-harvest Food Safety Laboratory for 
processing by FedExed. In the laboratory, approximately 1 g of feces were added to a 
tube of 9 mL Escherichia coli broth (EC; Difco, ThermoFisher). Tube were vortexed 
to obtain a good fecal suspension. One mL of the suspension were pipetted into a 1.5 
mL tube for DNA extraction (pre-enrichment) for PCR assay. The fecal suspension 
were incubated at 40° C for 6 hours. One mL of the suspension were pipetted into a 
tube for DNA extraction (post-enrichment) for PCR assay. 
4. Culture Method for Detection of E. coli O157:H7.   
An aliquot of the enriched fecal suspension were subjected to immune magnetic 
separation (IMS) procedure with Abraxis® (Warminster, PA) O157 IMS beads.  
Twenty-five microliters of the O157 bead suspensions were spread-plated onto sorbitol 
MacConkey with cefixime and tellurite (CT-SMAC) medium and plates will be 
incubated at 37° C for 20-24 hours. Up to six sorbitol-negative colonies from CT-
SMAC were randomly picked and inoculated individually onto blood agar plates 
(Remel) and incubated at 37° C for 24 hours. Isolates obtained from the CT-SMAC 
plate were tested for agglutination for O157 antigen by latex agglutination, and if 
positive, tested for indole production. Isolates positive for agglutination and indole 
were tested by a six-plex PCR assay that targets rfbEO157, fliCH7, eae, stx1, stx2, and 
ehxA genes (88). Confirmation of E. coli O157:H7 were based on a gene profile 
positive for rfbEO157, eae, fliCH7 and at least one Shiga-toxin gene (either stx1 or stx2). 
Positive isolates were stored in CryoCare™ beads (Key Scientific Products, Round 
Rock, TX). All 317 isolates were cultured onto tryptone soy agar (TSA; BD Difco) 
slants and shipped overnight in cold storage to the University of Maryland.  
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5. PCR Method of Detection of non-O157 Serogroups 
An aliquot of the fecal suspension (before and after enrichment) will be placed in 
1.5 ml microcentrifuge tube, boiled for 10 min and centrifuged at 9,300 x g for 5 min.  
The supernatant will be purified with a GeneClean DNA extraction kit (MP 
Biomedicals, Solon, OH) and then subjected to an 11-plex PCR (89) targeting O157 
and six major non-O157 serogroups (O26, O45, O103, O111, O121, O145) plus four 
virulence genes (stx1, stx2, eae, and ehxA).  
6. DNA extraction and whole genome sequencing 
DNA extraction of 317 isolates were performed by using the DNeasy Blood and 
Tissue kit with the protocol DNeasy Blood and Tissue – Bacterial Pellet – Standard on 
the QIAcube. By following the Illumina Miseq protocol, the DNA of each isolates were 
modified to appropriate concentration and sequenced on an Illumina Miseq by using 
Nextera XT DNA Library Preparation Kit and Miseq Reagent Kit V2 500 cycle 
(Illumina, San Diego, CA). 
7. Data analysis 
7.1 Genomic analysis 
De novo assembly was performed on Miseq raw reads by using SPAdes Genome 
Assembler 3.10.1 (Nurk, Bankevich et al., 2013). Quality check of the draft genomes 
was performed by using QUAST 4.0 (Gurevich et al., 2013). kSNP3 (Gardner, S.N., T. 
Slezak, and B.G. Hall. 2015.) was used to identify the SNPs of 317 draft genomes. 
Phylogenetic trees based on the SNP data was created by RAxML.  
(Need to be modified) stx and other gene identification was done using Python 3.5, 
Biopython, and BLAST, with parameters specified in the results (90, 91). A previously 
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published core-genome for all of E. coli was previously published and used to extract 
core-gene sequences using BLAST (92). We used the Virulence Factor Database as a 
reference to identify virulence genes in the genome assemblies (93). We used Genbank 
accessions NC_002128 and NZ_CP008807 for pO157Sakai and pSS17 gene references, 
respectively (94, 95). 
7.2 Clade identification 
Clade information of isolates were identified with BLAST as the clade structure 
based on SNPs differences in the study of Manning et al. (2008). A subtyping scheme 
based on 39 SNPs genotype was developed to distinguish of O157:H7 isolates into 
nine distinct evolutionary clades (96).  
7.3 Statistical analysis 
Analysis of variance (ANOVA) test was used to evaluate several groups of data: 
differences between the prevalence of O157 through three different diets, prevalence 
of O157 with and without ractopamine treatment, the prevalence of O157 on each 
isolation day of each diets treatment. A values of p<0.05 was considered significant of 




CHAPTER 3 Results 
1. Clade information though Pens 
The clade information of 286 isolates are shown in table 3.1. All 286 draft genomes 
were identified in three clades, which are clade 6, clade 7, and clade 8.  
Table 3.1 Clade information for each diet 
 
UIP DIP CON Total 
Clade 6 90 46 69 205 
Clade 7 12 29 8 49 
Clade 8 7 12 13 32 
Total 109 87 90 286 
The distribution of each clade for each diet is shown in figure 3.1. Overall, the 
majority of E. coli O157:H7 isolates (205/286, 71.7%) were identified as clade 6 strains. 
49 isolates (49/286, 17.1%) were clade 7 strains. 32 isolates (32/286, 11.2%) were clade 
8 strains. The total of 87 isolates in high degradable protein diet (DIP) group, 46 isolates 
(52.9%) were belong to clade 6 strains, 29(33.3%) were defined as clade 7 strains, and 
12 (13.8%) isolates were clade 8 (Figure 3.2). For high undegradable protein diet (UIP) 
group, 90 of 109 isolates (82.6%) were clade 6 strains, 12 (11%) isolates were identified 
as clade 7 strains, and only 7 of 109 (6.4%) isolates were clade 8 strains (Figure 3.3). 
The total of 90 isolates of control diet (CON) were also identified into the same three 
clades: 69 (76.7%) clade 6 strains, 8 (8.9%) clade 7 strains, and 13 (14.4%) clade 8 
strains (Figure 3.4). 
Forty-eight pens (18 for each diet group) were included in this study. For isolates 
of DIP group, clade 6 strains were found in 10 pens, clade 7 strains were found in 6 
pens, and clade 8 strains were occurred in 5 pens. Clade 6 strains were dominated in 8 
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(100%), 22 (100%), 31 (100%), 37 (100%), 43 (100%), 45 (100%) pens. Clade 7 strains 
were found to be domination in 11 (66.7%), 15 (100%), 18 (100%), 29 (75%), 41 
(100%) pens. Clade 8 strains were found in 5 pens which 2 of 5 pens were dominated 
by them: 1 (83.3%), 20 (100%) (Figure 2). For UIP group strains, clade 6 strains 
dominated in most of the pens: 3 (83.3%), 6 (75%), 9 (100%), 12(100%), 26 (100%), 
28 (100%), 33 (100%), 36 (100%), 38 (94.4%), 40 (100%), 46 (100%), and 48 (100%). 
Clade 7 strains were identified in 4 pens and dominated in 14 (100%), 17 (66.7%) pens. 






























Figure 3.2 Clade information of each pens with DIP diet 
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Figure 3.4 Clade information of each pens with CON diet 
2. Clade profiles with collection dates 
Overall fecal prevalence of E. coli O157:H7 of each diet was shown in figure 3.5. 
For UIP diet group, there was a tendency of increasing between the first and the second 
sample collection (July 30 and August 12), but then decreased to 28.1% and 21.9% at 
the third and fourth collection day. The prevalence of E. coli O157:H7 in control diet 
group has been decreasing through the four collection day. The prevalence in DIP diet 
group shown a different pattern which ranged from 6.3% at the first collection day to 
43.8% at the last collection day. The last collection date of each block contained 
ractopamine treatment. The prevalence of E. coli O157:H7 with and without 
ractopamine treatment on last collection day were shown in figure 3.6. The positive 
rate of E. coli O157:H7 for each diet group without ractopamine treatment were 12.5% 
for UIP, 45.8% for DIP, and 6.3% for CON. With ractopamine treatment, the positive 
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Figure 3.5 Prevalence of E. coli O157:H7 of each diet (n = 96) 
 
Figure 3.6 Prevalence of E. coli O157:H7 with and without ractopamine 
treatment (n=48) 
After combine the clade information and the prevalence data through times, 
the results have shown more clear information. The population tendency of E. coli 
O157:H7 of UIP and CON diet group had been declining over months (Figure 3.7, 
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Figure 3.9). Figure 3.7 shown the prevalence of E. coli O157:H7 of UIP diet 
group with clade information. Although clade 8 strains were collected on the last 
collection day, none of them were associated with ractopamine treatment (Figure 
3.8). The results of CON diet group shown the similar pattern with the results of 
UIP diet group (Figure 3.9 and figure 3.10).  
 
Figure 3.7 Prevalence of E. coli O157:H7 on each collection day of UIP group 




Figure 3.8 Relative prevalence of E. coli O157:H7 with UIP diet between rh 
treatment and without rh treatment (n=48) 
 
Figure 3.9 Prevalence of E. coli O157:H7 on each collection day of CON 
group with clade information (n=96) 
 
Figure 3.10 Relative prevalence of E. coli O157:H7 with CON diet between 
rh treatment and without rh treatment (n=48) 
For DIP diet group, the prevalence of E. coli O157:H7 on each collection day 
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and clade information were shown in figure 3.11. The positive rate increased to 
43.8% on the last set of collection day. More clade 6 and clade 7 strains associated 
with rh treatment were collected, but clade 8 strains appeared more without 
ractopamine treatment (Figure 3.12). However, we still cannot conclude that the 
effect of ractopamine on fecal shedding E. coli O157:H7. 
 
Figure 3.11 Prevalence of E. coli O157:H7 on each collection day of DIP group 




Figure 3.12 Relative prevalence of E. coli O157:H7 with DIP diet between 
rh treatment and without rh treatment (n=48) 
3. Virulence genes 
We blasted a database of known E. coli effectors were used along with some 
putative type III effector-like genes, plus other pathogenicity genes, such as hemolysins, 
against our genomes by using a cutoff of 90% sequence identity and 60% gene length 
for calling a gene present or absent. We used a process that assigned partial hits to genes 
if they met the sequence identity threshold, then added those lengths up to calculate the 
total gene length present. This process is more sensitive in calling genes present, but 
problems with assembly, such as low quality of the assembled draft genomes, may not 
be able to distinguish well between multiple alleles. (This paragraph need to be 
modified) 
The blast results showed the same information of shiga-toxin genes with PCR 
results: all isolates were positive for stx2 gene but no stx1 gene were found in all 
isolates. Stx2a gene were found in all clade 8 strains (n=32), stx2c gene were found in 
all clade 6 (n=205) and clade 7 (n=49) strains (table 2). 
Table 3.2 stx gene profiles 
 stx1 stx2a stx2c 
Clade 6 isolates (n=205) - - + 
Clade 7 isolates (n=49) - - + 




Among LEE-encoded genes, all isolates were positive for intimin (eae), 
translocated intimin receptor protein (tir), type III secretion effectors (espB, espD, 
espH), but all isolates were negative for espF gene (figure 3.13). For non-LEE-encoded 
type III secreted effectors, all clade 6 isolates (n=205) were negative for espX6 gene, 
but clade 7 (n=49) and 8 (n=32) isolates were all positive for espX6 gene. Two nle 
variants, nleF and nleH2 genes were only presented in all clade 6 (n=205) and clade 8 
(n=32) isolates but were not observed in any clade 7 (n=49) isolates. 
 
Figure 3.13 Selected virulence factors results 
The LEE pathogenicity island chromosomally encodes for the intimin gene (eae) 
for attaching and effacing, translocated intimin receptor gene (tir), and Type III 
secretion system effector genes, all critical components of the Type III secretory system 
in EHEC and EPEC. These proteins (espB, espA, espD, tir) are exported via a type III 
secretion pathway similar to other specialized protein secretion systems that are shared 
among a variety of Gram-negative pathogens (97). Whereas an espF deletion mutant 
does not synthesize or secrete EspF, surprisingly it retains the ability to induce host 
signaling events, perform A/E activities, and invade host epithelial cells (97). 
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4. Phylogenetic relationships 
Phylogenetic tree was created by analyzing the SNP data of 286 isolates on 
RAxML with 100 bootstraps and the GTRGAMMA substitution model. The output file 
(.tree) was annotated using FigTree 1.4.2 (figure 3.14). Overall, the 286 isolates 
clustered based on the clade information. Outside the tree, there are two datasets: four 
collection days represented by orange rings and different diets of all strains. The first 
ring represents the first collection day (July 20th). The second ring indicates the second 
collection day (August 12th). The third ring represents third collection day (August 30th 
or September 2nd). The fourth ring represents fourth collection day (September 27th or 
October 4th). The fifth ring represents the different diets treatment of all strains: UIP is 




Figure 3.14 The phylogenetic tree based on SNP differences 
The clade in original phylogenetic tree were collapsed with branch length distance 
to leaves level below 0.02 (figure 3.15). The stx gene information is also shown in 
figure 8. In 32 clade 8 strains, only one strain (KSU146) was collected on the first 
isolation day; ten strains were collected on the second isolation day; two strains were 
collected on the third isolation day; nineteen strains were collected on the fourth 
isolation day (figure 3.13). Among 49 strains of clade 7, three strains were collected on 
the first isolation day; 15 strains were collected on the second isolation day; four strains 
were collected on the third isolation day; 27 strains were collected on fourth isolation 
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day (figure 3.14). Among 203 strains of clade 6, 59 strains were collected on the first 
isolation day; 57 strains were collected on the second isolation day; 58 strains were 
collected on the third isolation day; and 30 strains were collected on the fourth isolation 
day.  
 
Figure 3.15 SNP-based, collapsed phylogenetic tree 
5. SNPs analysis 
The SNPs count tree was performed by using Python. Numbers of SNPs of each 
isolates and branches of phylogenetic tree were observed. Among isolates of clade 8, 
KSU146 and KSU316 share 3 unique SNPs. KSU146 was collected on the first 
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collection day (July 20th) from pen 13 and no treatment was given. KSU316 was 
collected on the fourth collection day (October 4th) from pen 23 and UIP diet treatment 
was given. KSU117 and KSU081 shared three unique SNPs. These two isolates were 
collected from the fourth collection day and same diet treatment, DIP, were given. 
KSU081 was collected from pen 34, and KSU117 was collected from pen 1. There are 
two main lineages (7A and 7B) of isolates of clade 7. There are 63 SNPs differences 
between lineage 7A and lineage 7B. Among isolates of lineage 7A, KSU078 and 
KSU100 shared 6 unique SNPs. KSU078 was collected on the third collection day 
(September 2nd) from pen 11 with DIP diet treatment. KSU100 was collected on the 
fourth collection day (October 4th) from pen 14 with UIP diet treatment. Among isolates 
of lineage 7B, KSU212 and KSU202 shared 1 unique SNP. KSU212 was collected from 
the second collection day (August 12th) from pen 19 with CON diet treatment. KSU202 
was collected from the second collection day (August 12th) from pen 15 with DIP diet 
treatment. KSU203 and KSU303 shared 98 unique SNPs. These two isolates were 
collected from the same pen (pen 16) with same diet treatment (CON). However, 
KSU203 was collected on the second collection day (August 12th), and KSU303 was 
collected on the fourth collection day (October 4th). Among the isolates of clade 6, 
KSU264 and KSU263, shared 248 unique SNPs. They were collect from the same 
collection day (August 12th) and the same pen (pen 3). Same diet treatment, UIP, were 
given to pen 3. KSU 314 and KSU305 shared 84 unique SNPs. They were from 
different pens (pen 17 and 21) but collected from the same day (October 4th) with UIP 
diet treatment. KSU260 and KSU192 shared 2 unique SNPs. KSU260 was collected on 
the third collection day (August 30th) from pen 48 with UIP diet treatment. KSU 192 
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was collected on the second collection day (August 12th) from pen 9 with UIP diet 
treatment. KSU283 and KSU248 shared 3 unique SNPs. KSU 283 was collected on 
fourth collection day (September 27th) from pen 31 with DIP diet treatment. KSU 248 
was collected on third collection day (August 30th) from pen 40 with UIP diet treatment. 
KSU265 and KSU 189 shared 2 unique SNPs. KSU265 was collected on the third 
collection day (September 2nd) from pen 3 with UIP diet treatment. KSU 189 was 






CHAPTER 4 Discussion 
1. Clade lineages of E. coli O157:H7 isolates 
Based on the distribution of clade information of E. coli O157:H7 for each diet, 
differences were observed. More isolates (n=109) were collected from the pens with 
high undegradable protein diet than isolates collected from high degradable protein 
(n=87) and control diet (n=90). High percentage of isolates belonging to clade 6 were 
collected from pens with UIP diet and CON diet than from those with DIP diet. 
However, clade 7 isolates were the majority (33.33%) among pens with DIP diet. In 
addition, a lower percentage (6.42%) of clade 8 isolates were observed with UIP diet.  
2. Virulence genes 
For the 286 isolates, the distribution of stx genes information was very interesting. 
Only stx2a gene was found in the 32 isolates of clade 8. Strains of clade 8 lineage have 
caused two recent and unusually severe outbreaks linked to produce, are associated 
with HUS, and more frequently carry both stx2 and stx2c genes (Table 4.1). Eppinger, 
et al. (2011) reported that stx2a and stx2c genes were detected in clade 8 strains 
associated with the spinach and Taco Bell of outbreaks of E. coli O157:H7 infections 
in 2006. A second set of stx genes was found in lineage I/II clade 8 strains within Stx2c-
converting prophage integrated at the sbcB locus (ECH74115_2944) (98). The Stx2c 
prophage is a unique genomic feature of the spinach and Taco bell outbreak strains and 
the HUS strain EC508 (99). The Stx2-converting phages target two chromosomal loci 
(wrbA and argW) and could differ in their regulatory circuits and verotoxin expression 
levels (100). In addition, in clade 6 (n=205) and clade 7 (n=49) isolates, only stx2c 
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gene was identified. Unlike the Stx2 prophage, the Stx2c and Stx1 prophages seem to 
target preferentially the sbcB and yehV loci, respectively. These alterations in phage 
inventory and dynamics are mediated by unknown prophages and phage combinations 
as well as by varying integration loci (101), particularly in the stx converting phages 
(98). 
Table 4.1 Shiga toxin genes profile of isolates in this study and outbreak 
strains 
  stx1 stx2a stx2c 
Clade 6 isolates (n=205) - - + 
Clade 7 isolates (n=49) - - + 
Clade 8 isolates (n=32) - + - 
EC4045 - + + 
EC4042 - + + 
EC4113 - + + 
EC4076 - + + 
EC4084 - + + 
EC4127 - + + 
EC4191 - + + 
TW14359 (=EC1611) - + + 
EC4001 - + + 
EC4205 - + + 
3.  Re-sequence 
In this study, we performed whole genome sequencing on Illumina Miseq. The 
Illumina sequencing workflow was based on three simple steps: libraries are prepared 
from virtually any nucleic acid sample, amplified to produce clonal clusters, and 
sequenced using massively parallel synthesis (82). The density of clonal clusters has a 
large impact on sequencing performance in terms of data quality and total output (82). 
The goal of a sequencing run is to sequence at high enough densities to maximize total 
data output, while maintaining low enough densities to avoid the negative effects of 
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overclustering. The quality of results basically reflect on three data: reads passing filter 
(%PF), Q30 scores (%Q30), and the size of data output. The %PF is an indication of 
signal purity from each cluster. Overclustered flow cells typically have higher numbers 
of overlapping clusters, which leads to poor template generation, and then causes a 
decrease in the %PF metric. The Q30 score is a prediction of the probability of an 
incorrect base call 1 in 1000 times. The ratio of base intensity to background for each 
base is decreased due to overload signal intensities. This decrease often results in 
ambiguity during base calling, and leads to a decrease in data quality (82). The data 
output is based on the number of samples and the type of organisms.  
It was hard to identify the problem in terms of the multiple steps of manual 
experiment. We got three sequence results with low quality scores. The first run was 
performed on November 15th, 2016, with low %PF (52.54%), low average%Q30 
(64.91%), and low data output (1.75Gbp). We did another two separate libraries for 
another two runs which still showed low average%Q30 (31.43% and 32.98%). Then 
we tried third re-sequencing with the results of 89.33%PF and 83.35%Q30. In addition, 
we excluded the possible errors of manual library preparation and quantification. The 
reason why we got low quality of several runs is still unknown. We concluded that there 
might be some problem associated with the flow cells. The flow cell need to be clean-
up manually before sequencing. It is possible that the flow cells did not get cleaned 
thoroughly. Another reason might be the flow cells were damaged during the 
transporting. For further sequencing, methods such as qPCR can be performed to 
ensure the accuracy of quantification of library; Bioanalyzer or similar technology can 
be used for verification of library quality in order to check for library integrity, average 
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insert size, and the presence of contamination (82).
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CHAPTER 5 Conclusion 
This study undertook a whole genome comparative analysis of E. coli O157:H7 
isolates collected from feces of cattle fed with different composition of dietary 
protein. Our findings indicate that the change of dietary ingredients could affect the 
colonization and fecal shedding of STEC, and increased flow of undegradable protein 
may increase the shedding of E. coli O157. The pen layout could be a major factor of 
fecal shedding of STEC. However, it is important to note that other multiple factors 
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